Impact on health outcomes of treating all eligible large B-cell lymphoma patients with axicabtagene ciloleucel in Portugal - A modeling approach.
- DOI
- 10.1080/13696998.2026.2714649
- Published
- 2026 Dec
- Container
- Journal of medical economics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/13696998.2026.2714649,
title = {Impact on health outcomes of treating all eligible large B-cell lymphoma patients with axicabtagene ciloleucel in Portugal - A modeling approach.},
author = {Aragão F and Carneiro A and Carvalho S and Claudino C and Espada E and Moita F and João Silva M and Pereira S and Santos A},
year = {2026},
journal = {Journal of medical economics},
doi = {10.1080/13696998.2026.2714649},
url = {https://doi.org/10.1080/13696998.2026.2714649}
}RIS
TY - JOUR TI - Impact on health outcomes of treating all eligible large B-cell lymphoma patients with axicabtagene ciloleucel in Portugal - A modeling approach. AU - Aragão F AU - Carneiro A AU - Carvalho S AU - Claudino C AU - Espada E AU - Moita F AU - João Silva M AU - Pereira S AU - Santos A PY - 2026 JO - Journal of medical economics DO - 10.1080/13696998.2026.2714649 UR - https://doi.org/10.1080/13696998.2026.2714649 ER -
APA
F, A., A, C., S, C., C, C., E, E., F, M., M, J. S., S, P., & A, S. (2026). Impact on health outcomes of treating all eligible large B-cell lymphoma patients with axicabtagene ciloleucel in Portugal - A modeling approach.. Journal of medical economics. https://doi.org/10.1080/13696998.2026.2714649
Source records
- pubmed · retrieved 2026-09-26T21:05:17.606Z